GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Rad Laboratories Inc (STU:BUWA) » Definitions » Equity-to-Asset

Bio-Rad Laboratories (STU:BUWA) Equity-to-Asset : 0.71 (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Bio-Rad Laboratories Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Bio-Rad Laboratories's Total Stockholders Equity for the quarter that ended in Sep. 2024 was €6,747 Mil. Bio-Rad Laboratories's Total Assets for the quarter that ended in Sep. 2024 was €9,554 Mil. Therefore, Bio-Rad Laboratories's Equity to Asset Ratio for the quarter that ended in Sep. 2024 was 0.71.

The historical rank and industry rank for Bio-Rad Laboratories's Equity-to-Asset or its related term are showing as below:

STU:BUWA' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.65   Med: 0.71   Max: 0.77
Current: 0.71

During the past 13 years, the highest Equity to Asset Ratio of Bio-Rad Laboratories was 0.77. The lowest was 0.65. And the median was 0.71.

STU:BUWA's Equity-to-Asset is ranked better than
61.18% of 868 companies
in the Medical Devices & Instruments industry
Industry Median: 0.64 vs STU:BUWA: 0.71

Bio-Rad Laboratories Equity-to-Asset Historical Data

The historical data trend for Bio-Rad Laboratories's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Rad Laboratories Equity-to-Asset Chart

Bio-Rad Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.72 0.76 0.77 0.71 0.71

Bio-Rad Laboratories Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.71 0.71 0.72 0.70 0.71

Competitive Comparison of Bio-Rad Laboratories's Equity-to-Asset

For the Medical Devices subindustry, Bio-Rad Laboratories's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Rad Laboratories's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio-Rad Laboratories's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Bio-Rad Laboratories's Equity-to-Asset falls into.



Bio-Rad Laboratories Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Bio-Rad Laboratories's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=8015.619/11278.247
=0.71

Bio-Rad Laboratories's Equity to Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

Equity to Asset (Q: Sep. 2024 )=Total Stockholders Equity/Total Assets
=6746.561/9553.728
=0.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bio-Rad Laboratories  (STU:BUWA) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Bio-Rad Laboratories Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Bio-Rad Laboratories's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Rad Laboratories Business Description

Traded in Other Exchanges
Address
1000 Alfred Nobel Drive, Hercules, CA, USA, 94547
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Bio-Rad Laboratories Headlines

No Headlines